Stock Quality:
Last 7 days
-4.2%
Last 30 days
55.2%
Last 90 days
66.8%
Trailing 12 Months
-23.8%
FBRX RSI Chart
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
Historical Charts for Stock Metrics
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | 0 | 0 | 0 | 0 |
| 2019 | 13.5M | 9.0M | 4.5M | 36.0K |
| 2018 | 438.0K | 666.0K | 18.7M | 18.0M |
| 2017 | 76.8K | 104.5K | 132.3K | 160.0K |
| 2016 | 106.8K | 87.5K | 68.3K | 49.0K |
| 2015 | 0 | 0 | 0 | 126.0K |
| CEO | Dr. Paul A. Wagner Ph.D. |
|---|---|
| WEBSITE | fortebiorx.com |
| SECTOR | Healthcare |
| INDUSTRY | Biotechnology |
| EMPLOYEES | 7 |